Literature DB >> 11174785

Improved quality of life among patients with symptomatic carotid artery disease undergoing carotid endarterectomy.

A Dardik1, J Minor, C Watson, L J Hands.   

Abstract

BACKGROUND: Few studies have examined how carotid endarterectomy affects patients' view of their quality of life.
METHODS: Patients undergoing carotid endarterectomy from January 1996 to March 1997 at the John Radcliffe Hospital completed the United Kingdom Short Form 36 (SF-36) Health Survey Questionnaire before undergoing the procedure and again at 3 months afterward. Scores were compared with population normal values.
RESULTS: In 50 patients with symptomatic carotid artery disease, there was significant improvement in the SF-36 overall "change in health" score after the procedure compared with beforehand (61.0 +/- 3.7 vs 44.5 +/- 3.4, P =.003, Wilcoxon signed rank test). There were, however, no statistically significant differences in the group's mean SF-36 subscores after operation compared with before the procedure. The physical subscores were below age-adjusted healthy population means but similar to those for chronically ill patients (physical function subscore P =.015 vs normal, P =.89 vs ill; role limitation-physical subscore P =.007 vs normal, P =.89 vs ill). Patients with postoperative complications did not have an improved change in health score (-12.5 vs 22.0, P =.03, Mann-Whitney U test). There was no effect on change in health score because of other risk factors or in patients with contralateral carotid artery occlusion or a history of preoperative stroke.
CONCLUSIONS: Patients with symptomatic carotid artery disease undergoing an uncomplicated carotid endarterectomy perceive improved quality of life and overall health. There is no perception of worsened pain, energy, or physical or mental function after the procedure. These results confirm that patients believe that performance of carotid endarterectomy improves their overall health, supporting the surgical approach to carotid artery disease.

Entities:  

Mesh:

Year:  2001        PMID: 11174785     DOI: 10.1067/mva.2001.111735

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Effects of carotid or vertebrobasilar stent placement on cerebral perfusion and cognition.

Authors:  Roham Moftakhar; Aquilla S Turk; David B Niemann; Sayed Hussain; Sharad Rajpal; Thomas Cook; Madeleine Geraghty; Beverly Aagaard-Kienitz; Patrick A Turski; George C Newman
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Incidence, outcomes, and effect on quality of life of cranial nerve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial.

Authors:  Robert J Hye; Ariane Mackey; Michael D Hill; Jenifer H Voeks; David J Cohen; Kaijun Wang; MeeLee Tom; Thomas G Brott
Journal:  J Vasc Surg       Date:  2015-03-12       Impact factor: 4.268

3.  Effect of carotid artery stenting on cognitive function in patients with carotid artery stenosis: preliminary results.

Authors:  A S Turk; I Chaudry; V M Haughton; B P Hermann; H A Rowley; K Pulfer; B Aagaard-Kienitz; D B Niemann; P A Turski; R L Levine; C M Strother
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

Review 4.  Quality of life after carotid endarterectomy: a review of the literature.

Authors:  Mariusz Chabowski; Anna Grzebien; Agnieszka Ziomek; Karolina Dorobisz; Michał Leśniak; Dariusz Janczak
Journal:  Acta Neurol Belg       Date:  2017-06-21       Impact factor: 2.396

5.  Quality of life after carotid endarterectomy.

Authors:  Fernando José Abelha; Susana Quevedo; Henrique Barros
Journal:  BMC Cardiovasc Disord       Date:  2008-11-20       Impact factor: 2.298

6.  Health-related quality of life in ischaemic stroke survivors after carotid endarterectomy (CEA) and carotid artery stenting (CAS): confounder-controlled analysis.

Authors:  Mariusz Trystuła; Tomasz Tomaszewski; Maria Pąchalska
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-04-13       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.